Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of -0.38 is 49% above its 5-year average of -0.75, near the high end of its 5-year range (-1.04–-0.38).
23.23% above its 12-month average of -0.49.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-06-30): -0.09.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 22 comparable quarters.
EARNINGS PER SHARE (EPS)
-0.38
EARNINGS PER SHARE (EPS) AVG TTM
-0.49
EARNINGS PER SHARE (EPS) AVG 3Y
-0.66
EARNINGS PER SHARE (EPS) AVG 5Y
-0.75
EARNINGS PER SHARE (EPS) AVG 10Y
N/A
EARNINGS PER SHARE (EPS) AVG 15Y
N/A
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
+23.23%
CURRENT VS 3Y AVG
+42.64%
CURRENT VS 5Y AVG
+49.33%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Hyperfine, Inc.
Market Cap
$76.72M
Earnings Per Share (EPS)
-0.38
TTM Avg
-0.49
3Y Avg
-0.66
5Y Avg
-0.75
Market Cap
$77.54M
Earnings Per Share (EPS)
-2.22
TTM Avg
-3.23
3Y Avg
-3.23
5Y Avg
-3.23
Market Cap
$78.77M
Earnings Per Share (EPS)
-1.17
TTM Avg
-2.88
3Y Avg
-6.48
5Y Avg
-4.74
Market Cap
$79.62M
Earnings Per Share (EPS)
-1.15
TTM Avg
-1.39
3Y Avg
-1.49
5Y Avg
-1.37
Market Cap
$81.82M
Earnings Per Share (EPS)
-0.48
TTM Avg
-0.32
3Y Avg
-0.23
5Y Avg
-0.23
Market Cap
$72.73M
Earnings Per Share (EPS)
-0.50
TTM Avg
-0.75
3Y Avg
-1.17
5Y Avg
-1.06
Market Cap
$82.20M
Earnings Per Share (EPS)
-0.22
TTM Avg
-0.23
3Y Avg
-0.23
5Y Avg
-0.24
Market Cap
$83.04M
Earnings Per Share (EPS)
-1.88
TTM Avg
-2.06
3Y Avg
-2.07
5Y Avg
-1.66
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Hyperfine, Inc. (HYPR) | $76.72M | -0.38 | -0.49 | -0.66 | -0.75 |
| Neonc Technologies Holdings, Inc. (NTHI)vs › | $77.54M | -2.22 | -3.23 | -3.23 | -3.23 |
| Inovio Pharmaceuticals, Inc. (INO)vs › | $78.77M | -1.17 | -2.88 | -6.48 | -4.74 |
| Pulmonx Corporation (LUNG)vs › | $79.62M | -1.15 | -1.39 | -1.49 | -1.37 |
| LENSAR Inc (LNSR)vs › | $82.23M | N/A | -2.80 | -2.22 | -2.13 |
| Citius Oncology, Inc. (CTOR)vs › | $81.82M | -0.48 | -0.32 | -0.23 | -0.23 |
| Gain Therapeutics, Inc. (GANX)vs › | $72.73M | -0.50 | -0.75 | -1.17 | -1.06 |
| MediciNova, Inc. (MNOV)vs › | $82.20M | -0.22 | -0.23 | -0.23 | -0.24 |
| Acrivon Therapeutics, Inc. Common Stock (ACRV)vs › | $83.04M | -1.88 | -2.06 | -2.07 | -1.66 |
| MindWalk Holdings Corp. (HYFT)vs › | $71.89M | -0.26 | -0.44 | -0.60 | -0.58 |
Trailing EPS (TTM)
$-0.38
Forward EPS (Est.)
$-0.34
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | -0.43 |
| 2024-12-31 | -0.56 |
| 2023-12-31 | -0.62 |
| 2022-12-31 | -1.04 |
| 2021-12-31 | -0.92 |
| 2020-12-31 | -0.93 |
| 2019-12-31 | -4.06 |
